Comment on AbbVie to buy leukemia drugmaker Pharmacyclics for $21B

AbbVie to buy leukemia drugmaker Pharmacyclics for $21B

AbbVie Inc. says it is buying leukemia drugmaker Pharmacyclics for $21 billion. It is the first big acquisition for AbbVie since it last year pulled out of a deal to buy Irish drugmaker Shire after the U.S. government reduced the tax advantages of the offshore transaction. Pharmacyclics is known as the maker of Imbruvica, a drug that treats blood cancers. AbbVie said Thursday is offering $261.25 a share for Pharmacyclics under the cash and stock takeover. Pharmacyclics is recommending its shareholders accept the offer.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More World News